Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community
Go back to Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community| FRESENIUS MEDICAL CARE AG & CO. KGAA (NYSE: FMS) | Delayed: 23.70 +0.31 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.39 | 52 Week High | $47.52 | |||
| Open | $23.77 | 52 Week Low | $38.61 | |||
| Day High | $23.84 | P/E | N/A | |||
| Day Low | $23.61 | EPS | $0.00 | |||
| Volume | 490,977 | |||||
| Fresenius Medical Care Holdings (AMEX: FSMEM) | Delayed: 85.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.00 | 52 Week High | $85.00 | |||
| Open | $85.00 | 52 Week Low | $85.00 | |||
| Day High | $85.00 | P/E | N/A | |||
| Day Low | $85.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
